Skip to main content

CervoMed Inc.

CRVO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001053691

No open-market purchases or sales by CervoMed Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $5.42M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding CervoMed Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of CRVO: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders36137+2
Shares1.77M391.75M−22.4K (−1.3%)
Value$6.97M$154$5.42M−$1.56M (−22.3%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held CervoMed Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to CRVO in Q2 2026
InstitutionSharesValue% of portfolio
Woodline Partners LP688,987$2.14M0.01%
Sabby Management, LLC248,880$771.5K6.42%
Virtu Financial LLC24,093$75.0K0.00%
Summit Financial, LLC18,140$56.2K0.00%
Citigroup Inc664$2.06K0.00%
EverSource Wealth Advisors, LLC118$3660.00%
Rockefeller Capital Management L.P.13$400.00%

Sold out (5)

Institutions that held CervoMed Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of CRVO in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Millennium Management LLC208,908$823.1K
Renaissance Technologies LLC63,904$251.8K
XTX Topco Ltd38,487$151.6K
WFA of San Diego, LLC725$2.86K
Optiver Holding B.V.10$39

Not filed for Q2 2026 yet (1)

Institutions that held CervoMed Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CRVO in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
CWM, LLC39$154